163 related articles for article (PubMed ID: 23064035)
1. Successful treatment by adding duloxetine to pregabalin for peripheral neuropathy induced by paclitaxel.
Takenaka M; Iida H; Matsumoto S; Yamaguchi S; Yoshimura N; Miyamoto M
Am J Hosp Palliat Care; 2013 Nov; 30(7):734-6. PubMed ID: 23064035
[TBL] [Abstract][Full Text] [Related]
2. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.
Smith EM; Pang H; Cirrincione C; Fleishman S; Paskett ED; Ahles T; Bressler LR; Fadul CE; Knox C; Le-Lindqwister N; Gilman PB; Shapiro CL;
JAMA; 2013 Apr; 309(13):1359-67. PubMed ID: 23549581
[TBL] [Abstract][Full Text] [Related]
3. Drug treatment for chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer.
Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Okubo Y; Nakamura J; Takasumi M; Hashimoto M; Kato T; Kobashi R; Hikichi T; Ohira H
Fukushima J Med Sci; 2022 Apr; 68(1):1-10. PubMed ID: 35197393
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the Anti-Allodynic and Anti-Hyperalgesic Efficacy of a Glycine Transporter 2 Inhibitor Relative to Pregabalin, Duloxetine and Indomethacin in a Rat Model of Cisplatin-Induced Peripheral Neuropathy.
Kuo A; Corradini L; Nicholson JR; Smith MT
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34202809
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine Stress Axis-Dependence of Duloxetine Analgesia (Anti-Hyperalgesia) in Chemotherapy-Induced Peripheral Neuropathy.
Staurengo-Ferrari L; Bonet IJM; Araldi D; Green PG; Levine JD
J Neurosci; 2022 Jan; 42(3):405-415. PubMed ID: 34880120
[TBL] [Abstract][Full Text] [Related]
6. [A case of Paclitaxel-induced peripheral neuropathy successfully treated with duloxetine].
Nagashima S; Kiba T; Ogawa Y; Mura T; Kajiume S; Okada Y; Morii N; Takahashi H; Ichiba Y; Yamashiro H
Gan To Kagaku Ryoho; 2015 May; 42(5):617-9. PubMed ID: 25981658
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of the effects of venlafaxine and duloxetine on chemotherapy-induced peripheral neuropathy.
Farshchian N; Alavi A; Heydarheydari S; Moradian N
Cancer Chemother Pharmacol; 2018 Nov; 82(5):787-793. PubMed ID: 30105459
[TBL] [Abstract][Full Text] [Related]
8. Etodolac, a cyclooxygenase-2 inhibitor, attenuates paclitaxel-induced peripheral neuropathy in a mouse model of mechanical allodynia.
Ito S; Tajima K; Nogawa M; Inoue N; Kyoi T; Takahashi Y; Sasagawa T; Nakamura A; Kotera T; Ueda M; Yamashita Y; Banno K
J Pharmacol Exp Ther; 2012 Jul; 342(1):53-60. PubMed ID: 22460833
[TBL] [Abstract][Full Text] [Related]
9. Serotonin-norepinephrine reuptake inhibitors for the management of chemotherapy-induced peripheral neuropathy.
Aziz MT; Good BL; Lowe DK
Ann Pharmacother; 2014 May; 48(5):626-32. PubMed ID: 24577146
[TBL] [Abstract][Full Text] [Related]
10. Duloxetine for the treatment of painful diabetic peripheral neuropathy in Venezuela: economic evaluation.
Carlos F; Espejel L; Novick D; López R; Flores D
Medwave; 2015 Sep; 15(8):e6265. PubMed ID: 26460688
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: A retrospective study in Japan.
Hiramoto S; Asano H; Miyamoto T; Takegami M; Kawabata A
PLoS One; 2021; 16(12):e0261473. PubMed ID: 34972132
[TBL] [Abstract][Full Text] [Related]
12. A double blind, placebo controlled, phase II randomised cross-over trial investigating the use of duloxetine for the treatment of chemotherapy-induced peripheral neuropathy.
Battaglini E; Park SB; Barnes EH; Goldstein D
Contemp Clin Trials; 2018 Jul; 70():135-138. PubMed ID: 29680317
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of duloxetine for Paclitaxel-induced peripheral neuropathy treatment in gynecological cancer patients.
Otake A; Yoshino K; Ueda Y; Sawada K; Mabuchi S; Kimura T; Kobayashi E; Isobe A; Egawa-Takata T; Matsuzaki S; Fujita M; Kimura T
Anticancer Res; 2015 Jan; 35(1):359-63. PubMed ID: 25550572
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the Efficacy and Safety of Pregabalin and Duloxetine in Taxane-Induced Sensory Neuropathy: A Randomized Controlled Trial.
Salehifar E; Janbabaei G; Hendouei N; Alipour A; Tabrizi N; Avan R
Clin Drug Investig; 2020 Mar; 40(3):249-257. PubMed ID: 31925721
[TBL] [Abstract][Full Text] [Related]
15. Duloxetine prevents bortezomib and paclitaxel large-fiber chemotherapy-induced peripheral neuropathy (LF-CIPN) in sprague dawley rats.
Mansooralavi N; Khomula EV; Levine JD
Mol Pain; 2023; 19():17448069231185694. PubMed ID: 37338165
[TBL] [Abstract][Full Text] [Related]
16. Can pregabalin prevent paclitaxel-associated neuropathy?--An ACCRU pilot trial.
Shinde SS; Seisler D; Soori G; Atherton PJ; Pachman DR; Lafky J; Ruddy KJ; Loprinzi CL
Support Care Cancer; 2016 Feb; 24(2):547-553. PubMed ID: 26155765
[TBL] [Abstract][Full Text] [Related]
17. Comparative safety and tolerability of duloxetine vs. pregabalin vs. duloxetine plus gabapentin in patients with diabetic peripheral neuropathic pain.
Irving G; Tanenberg RJ; Raskin J; Risser RC; Malcolm S
Int J Clin Pract; 2014 Sep; 68(9):1130-40. PubMed ID: 24837444
[TBL] [Abstract][Full Text] [Related]
18. Pregabalin for chemotherapy-induced neuropathy: background and rationale for further study.
Davis M; Loprinzi C
Support Care Cancer; 2022 Nov; 30(11):8845-8853. PubMed ID: 35953729
[TBL] [Abstract][Full Text] [Related]
19. Duloxetine Compared with Pregabalin for Diabetic Peripheral Neuropathic Pain Management in Patients with Suboptimal Pain Response to Gabapentin and Treated with or without Antidepressants: A Post Hoc Analysis.
Tanenberg RJ; Clemow DB; Giaconia JM; Risser RC
Pain Pract; 2014 Sep; 14(7):640-8. PubMed ID: 24152185
[TBL] [Abstract][Full Text] [Related]
20. Behavioral, Electrophysiological, and Histological Characterization of a New Rat Model for Neoadjuvant Chemotherapy-Induced Neuropathic Pain: Therapeutic Potential of Duloxetine and Allopregnanolone Concomitant Treatment.
Matta C; Meyer L; Mensah-Nyagan AG; Taleb O
Neurotox Res; 2020 Jun; 38(1):145-162. PubMed ID: 32108299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]